tiprankstipranks
Trending News
More News >
Orgenesis (ORGS)
:ORGS
US Market

Orgenesis (ORGS) Technical Analysis

Compare
140 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Orgenesis’s (ORGS) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Orgenesis is a Sell.
Orgenesis’s (ORGS) 20-Day exponential moving average is 2.39, while Orgenesis’s (ORGS) share price is $2.48, making it a Sell.
Orgenesis’s (ORGS) 50-Day exponential moving average is 2.47, while Orgenesis’s (ORGS) share price is $2.48, making it a Sell.

Orgenesis (ORGS) Pivot Points

May 04, 2025, 11:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.04
2.10
2.19
2.25
2.34
2.40
2.49
Fibonacci
2.10
2.16
2.20
2.25
2.31
2.35
2.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Orgenesis (ORGS) Moving Averages

May 04, 2025, 11:08 PM
Period
Simple
Exponential
MA5
2.28Sell
2.28Sell
MA10
2.34Sell
2.31Sell
MA20
2.31Sell
2.39Sell
MA50
2.81Sell
2.47Sell
MA100
2.16Buy
2.54Sell
MA200
3.36Sell
3.55Sell
Orgenesis’s (ORGS) 10-Day exponential moving average is 2.31, while Orgenesis’s (ORGS) share price is $2.48, making it a Sell.
Orgenesis’s (ORGS) 100-Day exponential moving average is 2.54, while Orgenesis’s (ORGS) share price is $2.48, making it a Sell.
Orgenesis’s (ORGS) stock price is $2.48 and Orgenesis’s (ORGS) 50-day simple moving average is 2.81, creating a Sell signal.
Orgenesis’s (ORGS) stock price is $2.48 and Orgenesis’s (ORGS) 100-day simple moving average is 2.16, creating a Buy signal.
Orgenesis’s (ORGS) stock price is $2.48 and Orgenesis’s (ORGS) 200-day simple moving average is 3.36, creating a Sell signal.

Orgenesis (ORGS) Technical Indicators

May 04, 2025, 11:08 PM
Name
Value
Implied Action
RSI (14)
45.38
Neutral
STOCH (9,6)
19.14
Buy
STOCHRSI (14)
55.32
Neutral
MACD (12,26)
-0.11
Sell
ADX (14)
12.20
Buy
Williams %R
-50.00
Buy
CCI (14)
-38.88
Neutral
ATR (14)
0.34
-
Ultimate Oscillator
53.65
Neutral
ROC
13.27
Buy
Orgenesis’s (ORGS) Relative Strength Index (RSI) is 45.38, creating a Neutral signal.
Orgenesis’s (ORGS) Trend Strength Indicator (ADX) is 12.20, creating a Buy signal.
Orgenesis’s (ORGS) Commodity Channel Index (CCI) is -38.88, creating a Neutral signal.
Orgenesis’s (ORGS) Price Rate of Change (ROC) is 13.27, creating a Buy signal.

FAQ

Is ORGS a Buy, Hold, or Sell?
Based on ORGS’s technical indicators, ORGS is a Sell.
    What is ORGS’s RSI (14)?
    ORGS’s RSI (14) is 45.38, which suggests ORGS is a Neutral.
      What is ORGS’s MACD?
      ORGS’s MACD is -0.11, which suggests ORGS is a Sell.
        What is ORGS’s 5-day moving average?
        ORGS’s 5-day moving average is 2.28, which suggests ORGS is a Sell.
          What is ORGS’s 20-day moving average?
          ORGS 20-day moving average is 2.31, which suggests ORGS is a Sell.
            What is ORGS’s 50-day moving average?
            ORGS’s 50-day moving average is 2.81, which suggests ORGS is a Sell.
              What is ORGS’s 200-day moving average?
              ORGS’s 200-day moving average is 3.36, which suggests ORGS is a Sell.
                What is ORGS’s Williams % R (14)?
                ORGS’s Williams % R (14) is -50.00, which suggests ORGS is a Buy.
                  What is ORGS’s CCI (14)?
                  ORGS’s CCI (14) is -38.88, which suggests ORGS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis